Vident Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Sell |
2,449
-173
| -7% | -$90.8K | 0.01% | 641 |
|
|
2025
Q1 | $1.66M | Sell |
2,622
-2,055
| -44% | -$1.3M | 0.02% | 544 |
|
|
2024
Q4 | $3.33M | Buy |
4,677
+3,254
| +229% | +$2.32M | 0.06% | 296 |
|
|
2024
Q3 | $1.5M | Sell |
1,423
-4,449
| -76% | -$4.68M | 0.04% | 494 |
|
|
2024
Q2 | $6.17M | Sell |
5,872
-18,860
| -76% | -$19.8M | 0.17% | 117 |
|
|
2024
Q1 | $23.8M | Buy |
24,732
+4,860
| +24% | +$4.68M | 0.5% | 35 |
|
|
2023
Q4 | $17.5M | Sell |
19,872
-1,990
| -9% | -$1.75M | 0.44% | 46 |
|
|
2023
Q3 | $18M | Buy |
+21,862
| New | +$18M | 0.56% | 32 |
|